Individualized Versus Conventional Perioperative Blood Pressure Management

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age45+
SponsorSeoul National University Hospital

About this trial

Study objective: To compare the effect of different perioperative blood pressure management strategies on major postoperative adverse outcomes / Study design: a multicenter, randomized controlled trial / Participants: 1896 patients undergoing major non-cardiac surgery / Methods: Patients are randomized into two groups, the individualized strategy (maintaining perioperative mean arterial pressure and systolic blood pressure more than -20% of their baseline values) or the conventional strategy (maintaining perioperative mean arterial pressure ≥65 mmHg and systolic blood pressure ≥90 mmHg in all patients). Then, the frequency of major postoperative adverse outcomes occurring within 7 postoperative days or before discharge (whichever occurs first). / Primary outcome: a composite of all-cause death, stroke, myocardial infarction, new or worsening congestive heart failure, unplanned coronary revascularization, and acute kidney injury, occuring within 7 postoperative days or before discharge (whichever occurs first).

Eligibility criteria

Qualifiers

Patients aged ≥65 or,

those aged ≥45 with a history of coronary artery disease, peripheral vascular disease, transient ischemic attack/stroke, or congestive heart failure,

undergoing non-cardiac surgery under general anesthesia with an anticipated duration of ≥2 hours.

Disqualifiers

Emergency surgery

Organ transplantation surgery

Brain/carotid artery surgery

American Society of Anesthesiologists physical status 5 or 6

Trial design

Treatments tested in this trial

  • Individualized perioperative blood pressure management strategy
  • Conventional perioperative blood pressure management strategy

Treatment groups

1,896 Participants
are divided into 2 treatment groups